BFA
CARM

BlackRock Fund Advisors’s Carisma Therapeutics CARM Stock Holding History

BlackRock Fund Advisors’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Buy
118
+27
+30% +$1.19K ﹤0.01% 4055
2016
Q3 		$5K Buy
91
+10
+12% +$745 ﹤0.01% 4060
2016
Q2 		$3K Sell
81
-1,453
-95% -$36.8K ﹤0.01% 4164
2016
Q1 		$10K Sell
1,534
-127
-8% -$1.76K ﹤0.01% 3977
2015
Q4 		$100K Buy
+1,661
New +$94.3K ﹤0.01% 3730
2015
Q2 		– Sell
-5,764
Closed -$1.03M – 3873
2015
Q1 		$1.03M Sell
5,764
-9
-0.2% -$1.97K ﹤0.01% 3213
2014
Q4 		$1.37M Buy
5,773
+865
+18% +$194K ﹤0.01% 3204
2014
Q3 		$1.09M Sell
4,908
-190
-4% -$45.1K ﹤0.01% 3190
2014
Q2 		$1.34M Sell
5,098
-461
-8% -$114K ﹤0.01% 3148
2014
Q1 		$1.8M Buy
+5,559
New +$1.66M ﹤0.01% 3148

Other funds holding CARM

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $2.24B AUM 17.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return